Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway (Q39680200)
scientific article published on 14 July 2010
Language:
(P31) (Q13442814)
(P50) (Q19959784)
(Q73523499)
(Q20950329)
(P304) 6313-6324
(P407) (Q1860)
(P433) 15
(P478) 70
(P577) Wednesday, July 14, 2010
(P921) (Q424361)
(Q424213)
(P1433) (Q326097)
(P1476) "Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway" (language: en)
(P2093) Margaret A Park
Clint Mitchell
Guo Zhang
Adly Yacoub
Jeremy Allegood
Roland Reinehr
Andrew Larner
Paul B Fisher
Christina Voelkel-Johnson
Besim Ogretmen
Steven Grant
(P2860) (Q37229551)
(Q37268123)
(Q37268127)
(Q37378567)
(Q37123974)
(Q36982745)
(Q36979035)
(Q37172903)
(Q36922674)
(Q28568378)
(Q38870039)
(Q37034876)
(Q36944179)
(Q36875829)
(Q35950143)
(Q36817095)
(Q36760964)
(Q36733777)
(Q34541094)
(Q36407379)
(Q36395200)
(Q36373477)
(Q27860562)
(Q35208830)
(Q30333358)
(Q35193642)
(Q30453010)
(Q33946679)
(Q34219273)
(Q40093939)
(Q40102679)
(Q40106651)
(Q40149920)
(Q40383692)
(Q40661974)
(Q40662652)
(Q41819191)
(Q42800979)
(Q43172447)
(Q44930505)
(Q44927198)
(Q46689478)
(Q53898623)
(Q44683463)
(Q43792226)
other details
description scientific article published on 14 July 2010

External Links